Literature DB >> 455015

Arthritis and neuralgic amyotrophy due to Yersinia enterocolitica.

D Y Bulgen, B L Hazleman, R E Warren.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 455015      PMCID： PMC1598982          DOI： 10.1136/bmj.1.6173.1250

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease.

Authors:  K Aho; P Ahvonen; A Lassus; K Sievers; A Tiilikainen
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

Review 2.  [Human "Yersinia enterocolitica" infections in 1970, with a report of 642 recent cases. Clinical aspects and epidemiologic perspectives].

Authors:  H H Mollaret
Journal:  Pathol Biol (Paris)       Date:  1971-02

3.  Arthritis associated with Yersinia enterocolitica infection.

Authors:  P Ahvonen; K Sievers; K Aho
Journal:  Acta Rheumatol Scand       Date:  1969

4.  Human yersiniosis in Finland. II. Clinical features.

Authors:  P Ahvonen
Journal:  Ann Clin Res       Date:  1972-02
  4 in total
  5 in total

1.  Reactive arthritis due to Yersinia enterocolitica.

Authors:  J A Foley; J A Mathews
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

2.  Atlanto-axial dislocation in an 18-year-old female with Yersinia arthritis.

Authors:  A H Vilppula; T U Jussila; A M Kokko
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

3.  Yersinia arthritis: a clinical, immunological, and family study of 2 cases.

Authors:  P J Sheldon; N S Mair; E Fox
Journal:  Ann Rheum Dis       Date:  1982-04       Impact factor: 19.103

4.  Post-yersinial arthritis in Cleveland, England.

Authors:  J N Fordham; S Maitra
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

5.  Yersinia arthritis: demonstration of occult enteritis by 111indium leucocyte scanning.

Authors:  R M Bernstein; C G Mackworth-Young; S H Saverymutu; S Gupta; J P England; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.